Comparison of three regimens of Parlodel-SRO in levodopa-treated parkinsonians : a randomized double-lind crossover study
Identifieur interne : 001A16 ( PascalFrancis/Checkpoint ); précédent : 001A15; suivant : 001A17Comparison of three regimens of Parlodel-SRO in levodopa-treated parkinsonians : a randomized double-lind crossover study
Auteurs : H. Allain ; F. Le Coz ; F. Goulley ; F. Brunet-Bourgin ; Y. Loria ; D. Bentue-Ferrer ; R. Decombe ; J.-M. Reymann ; P. Chaumet-Riffaud ; J.-M. GandonSource :
- International journal of clinical pharmacology, therapy and toxicology : (1980) [ 0174-4879 ] ; 1991.
Descripteurs français
- Pascal (Inist)
- Wicri :
- topic : Homme.
English descriptors
- KwdEn :
Affiliations:
Links toward previous steps (curation, corpus...)
Links to Exploration step
Pascal:91-0549078Le document en format XML
<record><TEI><teiHeader><fileDesc><titleStmt><title xml:lang="en" level="a">Comparison of three regimens of Parlodel-SRO in levodopa-treated parkinsonians : a randomized double-lind crossover study</title>
<author><name sortKey="Allain, H" sort="Allain, H" uniqKey="Allain H" first="H." last="Allain">H. Allain</name>
</author>
<author><name sortKey="Le Coz, F" sort="Le Coz, F" uniqKey="Le Coz F" first="F." last="Le Coz">F. Le Coz</name>
</author>
<author><name sortKey="Goulley, F" sort="Goulley, F" uniqKey="Goulley F" first="F." last="Goulley">F. Goulley</name>
</author>
<author><name sortKey="Brunet Bourgin, F" sort="Brunet Bourgin, F" uniqKey="Brunet Bourgin F" first="F." last="Brunet-Bourgin">F. Brunet-Bourgin</name>
</author>
<author><name sortKey="Loria, Y" sort="Loria, Y" uniqKey="Loria Y" first="Y." last="Loria">Y. Loria</name>
</author>
<author><name sortKey="Bentue Ferrer, D" sort="Bentue Ferrer, D" uniqKey="Bentue Ferrer D" first="D." last="Bentue-Ferrer">D. Bentue-Ferrer</name>
</author>
<author><name sortKey="Decombe, R" sort="Decombe, R" uniqKey="Decombe R" first="R." last="Decombe">R. Decombe</name>
</author>
<author><name sortKey="Reymann, J M" sort="Reymann, J M" uniqKey="Reymann J" first="J.-M." last="Reymann">J.-M. Reymann</name>
</author>
<author><name sortKey="Chaumet Riffaud, P" sort="Chaumet Riffaud, P" uniqKey="Chaumet Riffaud P" first="P." last="Chaumet-Riffaud">P. Chaumet-Riffaud</name>
</author>
<author><name sortKey="Gandon, J M" sort="Gandon, J M" uniqKey="Gandon J" first="J.-M." last="Gandon">J.-M. Gandon</name>
</author>
</titleStmt>
<publicationStmt><idno type="wicri:source">INIST</idno>
<idno type="inist">91-0549078</idno>
<date when="1991">1991</date>
<idno type="stanalyst">PASCAL 91-0549078 INIST</idno>
<idno type="RBID">Pascal:91-0549078</idno>
<idno type="wicri:Area/PascalFrancis/Corpus">001B73</idno>
<idno type="wicri:Area/PascalFrancis/Curation">001478</idno>
<idno type="wicri:Area/PascalFrancis/Checkpoint">001A16</idno>
<idno type="wicri:explorRef" wicri:stream="PascalFrancis" wicri:step="Checkpoint">001A16</idno>
</publicationStmt>
<sourceDesc><biblStruct><analytic><title xml:lang="en" level="a">Comparison of three regimens of Parlodel-SRO in levodopa-treated parkinsonians : a randomized double-lind crossover study</title>
<author><name sortKey="Allain, H" sort="Allain, H" uniqKey="Allain H" first="H." last="Allain">H. Allain</name>
</author>
<author><name sortKey="Le Coz, F" sort="Le Coz, F" uniqKey="Le Coz F" first="F." last="Le Coz">F. Le Coz</name>
</author>
<author><name sortKey="Goulley, F" sort="Goulley, F" uniqKey="Goulley F" first="F." last="Goulley">F. Goulley</name>
</author>
<author><name sortKey="Brunet Bourgin, F" sort="Brunet Bourgin, F" uniqKey="Brunet Bourgin F" first="F." last="Brunet-Bourgin">F. Brunet-Bourgin</name>
</author>
<author><name sortKey="Loria, Y" sort="Loria, Y" uniqKey="Loria Y" first="Y." last="Loria">Y. Loria</name>
</author>
<author><name sortKey="Bentue Ferrer, D" sort="Bentue Ferrer, D" uniqKey="Bentue Ferrer D" first="D." last="Bentue-Ferrer">D. Bentue-Ferrer</name>
</author>
<author><name sortKey="Decombe, R" sort="Decombe, R" uniqKey="Decombe R" first="R." last="Decombe">R. Decombe</name>
</author>
<author><name sortKey="Reymann, J M" sort="Reymann, J M" uniqKey="Reymann J" first="J.-M." last="Reymann">J.-M. Reymann</name>
</author>
<author><name sortKey="Chaumet Riffaud, P" sort="Chaumet Riffaud, P" uniqKey="Chaumet Riffaud P" first="P." last="Chaumet-Riffaud">P. Chaumet-Riffaud</name>
</author>
<author><name sortKey="Gandon, J M" sort="Gandon, J M" uniqKey="Gandon J" first="J.-M." last="Gandon">J.-M. Gandon</name>
</author>
</analytic>
<series><title level="j" type="main">International journal of clinical pharmacology, therapy and toxicology : (1980)</title>
<title level="j" type="abbreviated">Int. j. clin. pharmacol. ther. toxicol. : (1980)</title>
<idno type="ISSN">0174-4879</idno>
<imprint><date when="1991">1991</date>
</imprint>
</series>
</biblStruct>
</sourceDesc>
<seriesStmt><title level="j" type="main">International journal of clinical pharmacology, therapy and toxicology : (1980)</title>
<title level="j" type="abbreviated">Int. j. clin. pharmacol. ther. toxicol. : (1980)</title>
<idno type="ISSN">0174-4879</idno>
</seriesStmt>
</fileDesc>
<profileDesc><textClass><keywords scheme="KwdEn" xml:lang="en"><term>Antiparkinson agent</term>
<term>Bromocryptine</term>
<term>Chemotherapy</term>
<term>Clinical trial</term>
<term>Controlled release form</term>
<term>Controlled therapeutic trial</term>
<term>D2 Dopamine receptor</term>
<term>Dopa</term>
<term>Dopamine agonist</term>
<term>Dosage form</term>
<term>Drug combination</term>
<term>Human</term>
<term>Nervous system diseases</term>
<term>Parkinson disease</term>
<term>Treatment</term>
</keywords>
<keywords scheme="Pascal" xml:lang="fr"><term>Antiparkinsonien</term>
<term>Stimulant dopaminergique</term>
<term>Association médicamenteuse</term>
<term>Forme pharmaceutique</term>
<term>Traitement</term>
<term>Chimiothérapie</term>
<term>Homme</term>
<term>Système nerveux pathologie</term>
<term>Récepteur dopaminergique D2</term>
<term>Forme libération contrôlée</term>
<term>Parkinson maladie</term>
<term>Essai thérapeutique contrôlé</term>
<term>Dopa</term>
<term>Bromocriptine</term>
<term>Essai clinique</term>
</keywords>
<keywords scheme="Wicri" type="topic" xml:lang="fr"><term>Homme</term>
</keywords>
</textClass>
</profileDesc>
</teiHeader>
</TEI>
<inist><standard h6="B"><pA><fA01 i1="01" i2="1"><s0>0174-4879</s0>
</fA01>
<fA02 i1="01"><s0>IJCPB5</s0>
</fA02>
<fA03 i2="1"><s0>Int. j. clin. pharmacol. ther. toxicol. : (1980)</s0>
</fA03>
<fA05><s2>29</s2>
</fA05>
<fA06><s2>8</s2>
</fA06>
<fA08 i1="01" i2="1" l="ENG"><s1>Comparison of three regimens of Parlodel-SRO in levodopa-treated parkinsonians : a randomized double-lind crossover study</s1>
</fA08>
<fA11 i1="01" i2="1"><s1>ALLAIN (H.)</s1>
</fA11>
<fA11 i1="02" i2="1"><s1>LE COZ (F.)</s1>
</fA11>
<fA11 i1="03" i2="1"><s1>GOULLEY (F.)</s1>
</fA11>
<fA11 i1="04" i2="1"><s1>BRUNET-BOURGIN (F.)</s1>
</fA11>
<fA11 i1="05" i2="1"><s1>LORIA (Y.)</s1>
</fA11>
<fA11 i1="06" i2="1"><s1>BENTUE-FERRER (D.)</s1>
</fA11>
<fA11 i1="07" i2="1"><s1>DECOMBE (R.)</s1>
</fA11>
<fA11 i1="08" i2="1"><s1>REYMANN (J.-M.)</s1>
</fA11>
<fA11 i1="09" i2="1"><s1>CHAUMET-RIFFAUD (P.)</s1>
</fA11>
<fA11 i1="10" i2="1"><s1>GANDON (J.-M.)</s1>
</fA11>
<fA14 i1="01"><s1>Univ. hosp., dep. neurology neuropharmacology</s1>
<s2>Rennes 35033</s2>
<s3>FRA</s3>
<sZ>A11011000</sZ>
</fA14>
<fA20><s1>314-322</s1>
</fA20>
<fA21><s1>1991</s1>
</fA21>
<fA23 i1="01"><s0>ENG</s0>
</fA23>
<fA43 i1="01"><s1>INIST</s1>
<s2>15902</s2>
<s3>354000012495080050</s3>
</fA43>
<fA44><s0>0000</s0>
</fA44>
<fA45><s0>1 p.</s0>
</fA45>
<fA47 i1="01" i2="1"><s0>91-0549078</s0>
</fA47>
<fA60><s1>P</s1>
</fA60>
<fA61><s0>A</s0>
</fA61>
<fA64 i2="1"><s0>International journal of clinical pharmacology, therapy and toxicology : (1980)</s0>
</fA64>
<fA66 i1="01"><s0>DEU</s0>
</fA66>
<fC02 i1="01" i2="X"><s0>002B02B06</s0>
</fC02>
<fC03 i1="01" i2="X" l="FRE"><s0>Antiparkinsonien</s0>
</fC03>
<fC03 i1="02" i2="X" l="FRE"><s0>Stimulant dopaminergique</s0>
</fC03>
<fC03 i1="03" i2="X" l="FRE"><s0>Association médicamenteuse</s0>
</fC03>
<fC03 i1="04" i2="X" l="FRE"><s0>Forme pharmaceutique</s0>
</fC03>
<fC03 i1="05" i2="X" l="FRE"><s0>Traitement</s0>
</fC03>
<fC03 i1="06" i2="X" l="FRE"><s0>Chimiothérapie</s0>
</fC03>
<fC03 i1="07" i2="X" l="FRE"><s0>Homme</s0>
</fC03>
<fC03 i1="08" i2="X" l="FRE"><s0>Système nerveux pathologie</s0>
</fC03>
<fC03 i1="09" i2="X" l="FRE"><s0>Récepteur dopaminergique D2</s0>
</fC03>
<fC03 i1="10" i2="X" l="FRE"><s0>Forme libération contrôlée</s0>
</fC03>
<fC03 i1="11" i2="X" l="FRE"><s0>Parkinson maladie</s0>
</fC03>
<fC03 i1="12" i2="X" l="FRE"><s0>Essai thérapeutique contrôlé</s0>
</fC03>
<fC03 i1="13" i2="X" l="FRE"><s0>Dopa</s0>
</fC03>
<fC03 i1="14" i2="X" l="FRE"><s0>Bromocriptine</s0>
</fC03>
<fC03 i1="15" i2="X" l="FRE"><s0>Essai clinique</s0>
</fC03>
<fC03 i1="01" i2="X" l="ENG"><s0>Antiparkinson agent</s0>
</fC03>
<fC03 i1="02" i2="X" l="ENG"><s0>Dopamine agonist</s0>
</fC03>
<fC03 i1="03" i2="X" l="ENG"><s0>Drug combination</s0>
</fC03>
<fC03 i1="04" i2="X" l="ENG"><s0>Dosage form</s0>
</fC03>
<fC03 i1="05" i2="X" l="ENG"><s0>Treatment</s0>
</fC03>
<fC03 i1="06" i2="X" l="ENG"><s0>Chemotherapy</s0>
</fC03>
<fC03 i1="07" i2="X" l="ENG"><s0>Human</s0>
</fC03>
<fC03 i1="08" i2="X" l="ENG"><s0>Nervous system diseases</s0>
</fC03>
<fC03 i1="09" i2="X" l="ENG"><s0>D2 Dopamine receptor</s0>
</fC03>
<fC03 i1="10" i2="X" l="ENG"><s0>Controlled release form</s0>
</fC03>
<fC03 i1="11" i2="X" l="ENG"><s0>Parkinson disease</s0>
</fC03>
<fC03 i1="12" i2="X" l="ENG"><s0>Controlled therapeutic trial</s0>
</fC03>
<fC03 i1="13" i2="X" l="ENG"><s0>Dopa</s0>
</fC03>
<fC03 i1="14" i2="X" l="ENG"><s0>Bromocryptine</s0>
</fC03>
<fC03 i1="15" i2="X" l="ENG"><s0>Clinical trial</s0>
</fC03>
<fC03 i1="01" i2="X" l="SPA"><s0>Antiparkinsoniano</s0>
</fC03>
<fC03 i1="02" i2="X" l="SPA"><s0>Estimulante dopaminérgico</s0>
</fC03>
<fC03 i1="03" i2="X" l="SPA"><s0>Asociación medicamentosa</s0>
</fC03>
<fC03 i1="04" i2="X" l="SPA"><s0>Forma farmacéutica</s0>
</fC03>
<fC03 i1="05" i2="X" l="SPA"><s0>Tratamiento</s0>
</fC03>
<fC03 i1="06" i2="X" l="SPA"><s0>Quimioterapia</s0>
</fC03>
<fC03 i1="07" i2="X" l="SPA"><s0>Hombre</s0>
</fC03>
<fC03 i1="08" i2="X" l="SPA"><s0>Sistema nervioso patología</s0>
</fC03>
<fC03 i1="09" i2="X" l="SPA"><s0>Receptor dopaminérgico D2</s0>
</fC03>
<fC03 i1="10" i2="X" l="SPA"><s0>Forma liberación controlada</s0>
</fC03>
<fC03 i1="11" i2="X" l="SPA"><s0>Parkinson enfermedad</s0>
</fC03>
<fC03 i1="12" i2="X" l="SPA"><s0>Ensayo terapéutico controlado</s0>
</fC03>
<fC03 i1="13" i2="X" l="SPA"><s0>Dopa</s0>
</fC03>
<fC03 i1="15" i2="X" l="SPA"><s0>Ensayo clínico</s0>
</fC03>
<fN21><s1>137</s1>
</fN21>
<fN82><s1>NIM</s1>
</fN82>
</pA>
</standard>
</inist>
<affiliations><list></list>
<tree><noCountry><name sortKey="Allain, H" sort="Allain, H" uniqKey="Allain H" first="H." last="Allain">H. Allain</name>
<name sortKey="Bentue Ferrer, D" sort="Bentue Ferrer, D" uniqKey="Bentue Ferrer D" first="D." last="Bentue-Ferrer">D. Bentue-Ferrer</name>
<name sortKey="Brunet Bourgin, F" sort="Brunet Bourgin, F" uniqKey="Brunet Bourgin F" first="F." last="Brunet-Bourgin">F. Brunet-Bourgin</name>
<name sortKey="Chaumet Riffaud, P" sort="Chaumet Riffaud, P" uniqKey="Chaumet Riffaud P" first="P." last="Chaumet-Riffaud">P. Chaumet-Riffaud</name>
<name sortKey="Decombe, R" sort="Decombe, R" uniqKey="Decombe R" first="R." last="Decombe">R. Decombe</name>
<name sortKey="Gandon, J M" sort="Gandon, J M" uniqKey="Gandon J" first="J.-M." last="Gandon">J.-M. Gandon</name>
<name sortKey="Goulley, F" sort="Goulley, F" uniqKey="Goulley F" first="F." last="Goulley">F. Goulley</name>
<name sortKey="Le Coz, F" sort="Le Coz, F" uniqKey="Le Coz F" first="F." last="Le Coz">F. Le Coz</name>
<name sortKey="Loria, Y" sort="Loria, Y" uniqKey="Loria Y" first="Y." last="Loria">Y. Loria</name>
<name sortKey="Reymann, J M" sort="Reymann, J M" uniqKey="Reymann J" first="J.-M." last="Reymann">J.-M. Reymann</name>
</noCountry>
</tree>
</affiliations>
</record>
Pour manipuler ce document sous Unix (Dilib)
EXPLOR_STEP=$WICRI_ROOT/Wicri/Sante/explor/ParkinsonFranceV1/Data/PascalFrancis/Checkpoint
HfdSelect -h $EXPLOR_STEP/biblio.hfd -nk 001A16 | SxmlIndent | more
Ou
HfdSelect -h $EXPLOR_AREA/Data/PascalFrancis/Checkpoint/biblio.hfd -nk 001A16 | SxmlIndent | more
Pour mettre un lien sur cette page dans le réseau Wicri
{{Explor lien |wiki= Wicri/Sante |area= ParkinsonFranceV1 |flux= PascalFrancis |étape= Checkpoint |type= RBID |clé= Pascal:91-0549078 |texte= Comparison of three regimens of Parlodel-SRO in levodopa-treated parkinsonians : a randomized double-lind crossover study }}
![]() | This area was generated with Dilib version V0.6.29. | ![]() |